Works matching DE "DENOSUMAB"

Results: 657

Effects of denosumab on bone mineral density and bone metabolism in patients with end‐stage renal disease: A systematic review and meta‐analysis.

Published in:

Hemodialysis International, 2023, v. 27, n. 4, p. 352, doi. 10.1111/hdi.13098

By:

Gu, Zhaoyan;
Yang, Xuhui;
Wang, Yan;
Gao, Jianjun

Publication type:

Article

Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism.

Published in:

2023

By:

Zhang, Peiheng;
Yu, Yang;
Gao, Ying;
Yuan, Geheng;
Zhang, Junqing;
Wang, Wei

Publication type:

Case Study

Bilateral atypical femur fracture in a patient with breast cancer taking zoledronic acid and denosumab: A case report.

Published in:

Modern Rheumatology Case Reports, 2025, v. 9, n. 1, p. 41, doi. 10.1093/mrcr/rxae059

By:

Kazuhiko Hashimoto;
Tomohiko Ito;
Yuto Yamagishi;
Koji Goto

Publication type:

Article

Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12 Open Access.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 6, p. e1951, doi. 10.1210/clinem/dgae611

By:

Langdahl, Bente;
Chung, Yoon-Sok;
Plebanski, Rafal;
Czerwinski, Edward;
Dokoupilova, Eva;
Supronik, Jerzy;
Rosa, Jan;
Mydlak, Andrzej;
Rowińska-Osuch, Anna;
Baek, Ki-Hyun;
Urboniene, Audrone;
Mordaka, Robert;
Ahn, Sohui;
Rho, Young Hee;
Ban, Jisuk;
Eastell, Richard

Publication type:

Article

Early and multiple doses of zoledronate mitigates rebound bone loss following withdrawal of receptor activator of nuclear factor kappa-B ligand inhibition.

Published in:

Journal of Bone & Mineral Research, 2025, v. 40, n. 3, p. 413, doi. 10.1093/jbmr/zjaf008

By:

Kim, Albert S;
Taylor, Victoria E;
Castro-Martinez, Ariel;
Dhakal, Suraj;
Zamerli, Amjad;
Mohanty, Sindhu T;
Xiao, Ya;
Simic, Marija K;
Pantalone, Alyssa;
Chu, Julian;
Cheng, Tegan L;
Croucher, Peter I;
Center, Jacqueline R;
Girgis, Christian M;
McDonald, Michelle M

Publication type:

Article

Mechanisms to explain the overshoot in bone remodeling markers after denosumab discontinuation: are we there yet?

Published in:

2025

By:

Ramchand, Sabashini K;
McDonald, Michelle M

Publication type:

Editorial

The effects of denosumab on osteoclast precursors in postmenopausal women: a possible explanation for the overshoot phenomenon after discontinuation.

Published in:

Journal of Bone & Mineral Research, 2025, v. 40, n. 3, p. 301, doi. 10.1093/jbmr/zjae170

By:

Schini, Marian;
Gossiel, Fatma;
Saini, Tanya;
Banda, Peter;
Ward, Rachel;
Vilaca, Tatiane;
Eastell, Richard;
Fontalis, Andreas

Publication type:

Article

Risk factors for osteonecrosis of the jaw in patients with chronic kidney disease: a nested case-control study.

Published in:

Journal of Bone & Mineral Research, 2025, v. 40, n. 2, p. 262, doi. 10.1093/jbmr/zjae193

By:

Iseri, Ken;
Hida, Noriko

Publication type:

Article

Romosozumab following denosumab improves lumbar spine bone mineral density and trabecular bone score more than denosumab continuation in postmenopausal women.

Published in:

2025

By:

Ferrari, Serge

Publication type:

Editorial

Romosozumab following denosumab improves lumbar spine bone mineral density and trabecular bone score greater than denosumab continuation in postmenopausal women.

Published in:

Journal of Bone & Mineral Research, 2025, v. 40, n. 2, p. 184, doi. 10.1093/jbmr/zjae179

By:

Hong, Namki;
Shin, Sungjae;
Kim, Hyunjae;
Cho, Sung Joon;
Park, Jin Ah;
Rhee, Yumie

Publication type:

Article

Use of Denosumab and Serial Arterial Embolization Combination Therapy as an Alternative to Surgical Resection in a Case of Large Sacro‑Pelvic Giant Cell Tumor.

Published in:

Neurology India, 2023, v. 71, n. 2, p. 345, doi. 10.4103/0028-3886.375422

By:

Gupta, Kshitij;
Jain, Aakash P.;
Ahuja, Kaustubh;
Mittal, Samarth;
Kandwal, Pankaj

Publication type:

Article

Osteoporosis Management.

Published in:

Journal of Women's Health (15409996), 2020, v. 29, n. 3, p. 287, doi. 10.1089/jwh.2019.8195

By:

Tough DeSapri, Kristi;
Batur, Pelin

Publication type:

Article

Postmenopausal Osteoporosis: A Clinical Review.

Published in:

Journal of Women's Health (15409996), 2018, v. 27, n. 9, p. 1093, doi. 10.1089/jwh.2017.6706

By:

Watts, Nelson B.

Publication type:

Article

Treatments of osteoporosis increase bone material strength index in patients with low bone mass.

Published in:

Osteoporosis International, 2020, v. 31, n. 9, p. 1683, doi. 10.1007/s00198-020-05375-3

By:

Schoeb, M.;
Malgo, F.;
Peeters, J. J. M.;
Winter, E. M.;
Papapoulos, S. E.;
Appelman-Dijkstra, N. M.

Publication type:

Article

Response to letter to the editor OSIN-D-20-00441 re: "Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?".

Published in:

Osteoporosis International, 2020, v. 31, n. 8, p. 1599, doi. 10.1007/s00198-020-05492-z

By:

Tsvetov, G.;
Amitai, O.;
Diker-Cohen, T.

Publication type:

Article

Correspondence to "Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?".

Published in:

Osteoporosis International, 2020, v. 31, n. 8, p. 1597, doi. 10.1007/s00198-020-05491-0

By:

Ho, P.;
Tan, E.F.;
Su, S.;
Mallya, J.

Publication type:

Article

Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study.

Published in:

Osteoporosis International, 2020, v. 31, n. 8, p. 1507, doi. 10.1007/s00198-020-05391-3

By:

Chen, C.-L.;
Chen, N.-C.;
Wu, F.-Z.;
Wu, M.-T.

Publication type:

Article

Anorexia Nervosa with Markedly High Bone Turnover and Hyperphosphatemia During Refeeding Rectified by Denosumab.

Published in:

Osteoporosis International, 2020, v. 31, n. 7, p. 1395, doi. 10.1007/s00198-020-05307-1

By:

Kilbane, M. T.;
Crowley, R. K.;
Twomey, P. J.;
Maher, C.;
McKenna, M. J.

Publication type:

Article

A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosumab (PROMADE) study

Published in:

Osteoporosis International, 2020, v. 31, n. 7, p. 1251, doi. 10.1007/s00198-019-05271-5

By:

Yoshida, T.;
Kinoshita, H.;
Taniguchi, H.;
Yanishi, M.;
Sugi, M.;
Matsuda, T.

Publication type:

Article

Correction to: Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.

Published in:

2020

By:

McKee, H.;
Ioannidis, G.;
Lau, A.;
Treleaven, D.;
Gangji, A.;
Ribic, C.;
Wong-Pack, M.;
Papaioannou, A.;
Adachi, J.D.

Publication type:

Correction Notice

Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.

Published in:

Osteoporosis International, 2020, v. 31, n. 5, p. 973, doi. 10.1007/s00198-019-05267-1

By:

McKee, H.;
Ioannidis, G.;
Lau, A.;
Treleaven, D.;
Gangji, A.;
Ribic, C.;
Wong-Pack, M.;
Papaioannou, A.;
Adachi, J. D.

Publication type:

Article

Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis.

Published in:

Osteoporosis International, 2020, v. 31, n. 5, p. 983, doi. 10.1007/s00198-019-05200-6

By:

Ko, Y.;
Lee, G.;
Kim, B.;
Park, M.;
Jang, Y.;
Lim, W.

Publication type:

Article

Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data.

Published in:

Osteoporosis International, 2020, v. 31, n. 5, p. 961, doi. 10.1007/s00198-019-05183-4

By:

Ding, L.-L.;
Wen, F.;
Wang, H.;
Wang, D.-H.;
Liu, Q.;
Mo, Y.-X.;
Tan, X.;
Qiu, M.;
Hu, J.-X.

Publication type:

Article

Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?

Published in:

Osteoporosis International, 2020, v. 31, n. 4, p. 655, doi. 10.1007/s00198-019-05261-7

By:

Tsvetov, G.;
Amitai, O.;
Shochat, T.;
Shimon, I.;
Akirov, A.;
Diker-Cohen, T.

Publication type:

Article

Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink.

Published in:

Osteoporosis International, 2020, v. 31, n. 3, p. 533, doi. 10.1007/s00198-019-05228-8

By:

Morley, J.;
Moayyeri, A.;
Ali, L.;
Taylor, A.;
Feudjo-Tepie, M.;
Hamilton, L.;
Bayly, J.

Publication type:

Article

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates.

Published in:

Osteoporosis International, 2020, v. 31, n. 1, p. 181, doi. 10.1007/s00198-019-05233-x

By:

Miller, P.D.;
Pannacciulli, N.;
Malouf-Sierra, J.;
Singer, A.;
Czerwiński, E.;
Bone, H.G.;
Wang, C.;
Huang, S.;
Chines, A.;
Lems, W.;
Brown, J.P.

Publication type:

Article

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.

Published in:

Osteoporosis International, 2019, v. 30, n. 12, p. 2437, doi. 10.1007/s00198-019-05146-9

By:

Kendler, D.L.;
Bone, H.G.;
Massari, F.;
Gielen, E.;
Palacios, S.;
Maddox, J.;
Yan, C.;
Yue, S.;
Dinavahi, R.V.;
Libanati, C.;
Grauer, A.

Publication type:

Article

Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.

Published in:

Osteoporosis International, 2019, v. 30, n. 9, p. 1865, doi. 10.1007/s00198-019-05051-1

By:

Ban, J.K.;
Hao, B.B.;
McCarthy, L.;
Guilcher, S.J.T.;
Cadarette, S.M.

Publication type:

Article

Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?

Published in:

Osteoporosis International, 2019, v. 30, n. 9, p. 1817, doi. 10.1007/s00198-019-05066-8

By:

Kristensen, P. K.;
Ehrenstein, V.;
Shetty, N.;
Pedersen, A. B.

Publication type:

Article

Fracture risk following intermission of osteoporosis therapy.

Published in:

Osteoporosis International, 2019, v. 30, n. 9, p. 1733, doi. 10.1007/s00198-019-05002-w

By:

Dennison, E.M.;
Cooper, C.;
Kanis, J.A.;
Bruyère, O.;
Silverman, S.;
McCloskey, E.;
Abrahamsen, B.;
Prieto-Alhambra, D.;
Ferrari, S.

Publication type:

Article

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.

Published in:

Osteoporosis International, 2019, v. 30, n. 9, p. 1855, doi. 10.1007/s00198-019-05020-8

By:

Bilezikian, J.P.;
Lin, C.J.F.;
Brown, J.P.;
Wang, A.T.;
Yin, X.;
Ebeling, P.R.;
Fahrleitner-Pammer, A.;
Franek, E.;
Gilchrist, N.;
Miller, P.D.;
Simon, J.A.;
Valter, I.;
Zerbini, C.A.F.;
Libanati, C.;
Chines, A.

Publication type:

Article

Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study.

Published in:

Osteoporosis International, 2019, v. 30, n. 7, p. 1455, doi. 10.1007/s00198-019-04963-2

By:

Borek, D.M.;
Smith, R.C.;
Gruber, C.N.;
Gruber, B.L.

Publication type:

Article

Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.

Published in:

Osteoporosis International, 2019, v. 30, n. 5, p. 1111, doi. 10.1007/s00198-018-04820-8

By:

Lamy, O.;
Fernández-Fernández, E.;
Monjo-Henry, I.;
Stoll, D.;
Aubry-Rozier, B.;
Benavent-Núñez, D.;
Aguado, P.;
Gonzalez-Rodriguez, E.

Publication type:

Article

Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series.

Published in:

2019

By:

Andersen, J. D.;
Bünger, M. H.;
Rahbek, O.;
Hald, J. D.;
Harsløf, T.;
Langdahl, B. L.

Publication type:

Case Study

Severe hypophosphatemia induced by denosumab in a patient with osteomalacia and tenofovir disoproxil fumarate-related acquired Fanconi syndrome.

Published in:

2019

By:

Chung, T.-L.;
Chen, N.-C.;
Chen, C.-L.

Publication type:

Case Study

Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.

Published in:

Osteoporosis International, 2019, v. 30, n. 1, p. 241, doi. 10.1007/s00198-018-4688-1

By:

Miyaoka, D.;
Imanishi, Y.;
Ohara, M.;
Hayashi, N.;
Nagata, Y.;
Yamada, S.;
Mori, K.;
Emoto, M.;
Inaba, M.

Publication type:

Article

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies.

Published in:

Osteoporosis International, 2019, v. 30, n. 1, p. 71, doi. 10.1007/s00198-018-4687-2

By:

Kendler, D. L.;
Chines, A.;
Wang, A.;
Brandi, M. L.;
Papapoulos, S.;
Lewiecki, E. M.;
Reginster, J-Y.;
Muñoz Torres, M.;
Bone, H. G.

Publication type:

Article

A systematic review of factors affecting medication adherence among patients with osteoporosis.

Published in:

Osteoporosis International, 2018, v. 29, n. 12, p. 2623, doi. 10.1007/s00198-018-4759-3

By:

Yeam, C. T.;
Chia, S.;
Tan, H. C. C.;
Kwan, Y. H.;
Fong, W.;
Seng, J. J. B.

Publication type:

Article

The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.

Published in:

Osteoporosis International, 2018, v. 29, n. 12, p. 2659, doi. 10.1007/s00198-018-4658-7

By:

Tsuchie, H.;
Miyakoshi, N.;
Iba, K.;
Kasukawa, Y.;
Nozaka, K.;
Dohke, T.;
Kosukegawa, I.;
Aizawa, T.;
Maekawa, S.;
Abe, H.;
Takeshima, M.;
Tomite, T.;
Segawa, T.;
Ouchi, K.;
Kinoshita, H.;
Suzuki, M.;
Yamashita, T.;
Shimada, Y.

Publication type:

Article

Effects of osteoporosis drug treatments on cortical and trabecular bone in the femur using DXA-based 3D modeling.

Published in:

Osteoporosis International, 2018, v. 29, n. 10, p. 2323, doi. 10.1007/s00198-018-4624-4

By:

Winzenrieth, R.;
Humbert, L.;
Di Gregorio, S.;
Bonel, E.;
García, M.;
Del Rio, L.

Publication type:

Article

Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.

Published in:

Osteoporosis International, 2018, v. 29, n. 8, p. 1737, doi. 10.1007/s00198-018-4533-6

By:

Thongprayoon, C.;
Acharya, P.;
Acharya, C.;
Chenbhanich, J.;
Bathini, T.;
Boonpheng, B.;
Sharma, K.;
Wijarnpreecha, K.;
Ungprasert, P.;
Gonzalez Suarez, M.L.;
Cheungpasitporn, W.

Publication type:

Article

Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis.

Published in:

Osteoporosis International, 2018, v. 29, n. 7, p. 1627, doi. 10.1007/s00198-018-4492-y

By:

Ebina, K.;
Hirao, M.;
Hashimoto, J.;
Matsuoka, H.;
Iwahashi, T.;
Chijimatsu, R.;
Etani, Y.;
Okamura, G.;
Miyama, A.;
Yoshikawa, H.

Publication type:

Article

A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.

Published in:

Osteoporosis International, 2018, v. 29, n. 6, p. 1277, doi. 10.1007/s00198-018-4506-9

By:

Dell, R.;
Greene, D.

Publication type:

Article

Effects of bone remodeling agents following teriparatide treatment.

Published in:

Osteoporosis International, 2018, v. 29, n. 6, p. 1351, doi. 10.1007/s00198-018-4434-8

By:

Burkard, D.;
Kourtjian, E.;
Messingschlager, C.;
Sipahi, R.;
Beckett, T.;
Padley, M.;
Stubbart, J.

Publication type:

Article

Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib.

Published in:

Osteoporosis International, 2018, v. 29, n. 4, p. 999, doi. 10.1007/s00198-018-4385-0

By:

Binkley, N.;
Krueger, D.;
de Papp, A. E.

Publication type:

Article

Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.

Published in:

Osteoporosis International, 2018, v. 29, n. 3, p. 769, doi. 10.1007/s00198-017-4334-3

By:

Niimi, R.;
Kono, T.;
Nishihara, A.;
Hasegawa, M.;
Sudo, A.

Publication type:

Article

Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.

Published in:

Osteoporosis International, 2018, v. 29, n. 2, p. 467, doi. 10.1007/s00198-017-4308-5

By:

Martín-Merino, E.;
Petersen, I.;
Hawley, S.;
Álvarez-Gutierrez, A.;
Khalid, S.;
Llorente-Garcia, A.;
Delmestri, A.;
Javaid, M. K.;
Van Staa, T. P.;
Judge, A.;
Cooper, C.;
Prieto-Alhambra, D.

Publication type:

Article

Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.

Published in:

Osteoporosis International, 2018, v. 29, n. 1, p. 41, doi. 10.1007/s00198-017-4242-6

By:

Zanchetta, M. B.;
Boailchuk, J.;
Massari, F.;
Silveira, F.;
Bogado, C.;
Zanchetta, J. R.

Publication type:

Article

Two Biosimilars to Denosumab Win FDA Approval as Amgen and Sandoz Go to Court.

Published in:

Patient Care (Online), 2024, p. 1

By:

Joszt, Laura

Publication type:

Article

Retraction: Denosumab's Therapeutic Effect for Future Osteosarcopenia Therapy: A Systematic Review and Meta-Analysis.

Published in:: 2023
Publication type:: Correction Notice